Publishing research using ab16901? Please let us know so that we can cite the reference in this datasheet.

ab16901 has been referenced in 27 publications.

  • Dong H  et al. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer. Mol Cancer 18:3 (2019). PubMed: 30621694
  • Liu Y  et al. Efficacy and safety of TE/TEC/intensive paclitaxel neoadjuvant chemotherapy for the treatment of breast cancer. Oncol Lett 17:907-912 (2019). PubMed: 30655846
  • Xue L  et al. Ribonucleotide reductase subunit M2B deficiency leads to mitochondrial permeability transition pore opening and is associated with aggressive clinicopathologic manifestations of breast cancer. Am J Transl Res 10:3635-3649 (2018). PubMed: 30662615
  • Arnli MB  et al. Prognostic value of ErbB2/HER2 in human meningiomas. PLoS One 13:e0205846 (2018). PubMed: 30335819
  • Dökümcü K  et al. miR4673 improves fitness profile of neoplastic cells by induction of autophagy. Cell Death Dis 9:1068 (2018). PubMed: 30341280
  • Kang CC  et al. Electrophoretic cytopathology resolves ERBB2 forms with single-cell resolution. NPJ Precis Oncol 2:10 (2018). PubMed: 29872719
  • Fa Z  et al. MicroRNA-150 suppresses the growth and malignant behavior of papillary thyroid carcinoma cells via downregulation of MUC4. Exp Ther Med 16:45-52 (2018). PubMed: 29896226
  • Vanderhoeven F  et al. Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells. Oncotarget 9:26527-26542 (2018). PubMed: 29899874
  • Rici REG  et al. Combination therapy of canine osteosarcoma with canine bone marrow stem cells, bone morphogenetic protein and carboplatin in an in vivo model. Vet Comp Oncol N/A:N/A (2018). PubMed: 29781255
  • Sui M  et al. Upregulation of miR-125b is associated with poor prognosis and trastuzumab resistance in HER2-positive gastric cancer. Exp Ther Med 14:657-663 (2017). PubMed: 28672982
  • Shi Y  et al. SNP rs3202538 in 3'UTR region of ErbB3 regulated by miR-204 and miR-211 promote gastric cancer development in Chinese population. Cancer Cell Int 17:81 (2017). PubMed: 28924391
  • Li W  et al. ABCB1 3435TT andABCG2421CC genotypes were significantly associated with longer progression-free survival in Chinese breast cancer patients. Oncotarget 8:111041-111052 (2017). PubMed: 29340035
  • Goel S  et al. CDK4/6 inhibition triggers anti-tumour immunity. Nature 548:471-475 (2017). IHC ; Mouse . PubMed: 28813415
  • Sweeney WE  et al. Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease. World J Nephrol 6:188-200 (2017). PubMed: 28729967
  • Fan Y  et al. YAP-1 Promotes Tregs Differentiation in Hepatocellular Carcinoma by Enhancing TGFBR2 Transcription. Cell Physiol Biochem 41:1189-1198 (2017). PubMed: 28472799
  • Zhang YS  et al. Hybrid Microscopy: Enabling Inexpensive High-Performance Imaging through Combined Physical and Optical Magnifications. Sci Rep 6:22691 (2016). PubMed: 26975883
  • Wang Z  et al. The role of MAPK signaling pathway in the Her-2-positive meningiomas. Oncol Rep 36:685-95 (2016). PubMed: 27279438
  • Sanabria-Figueroa E  et al. Insulin-like growth factor-1 receptor signaling increases the invasive potential of human epidermal growth factor receptor 2-overexpressing breast cancer cells via Src-focal adhesion kinase and forkhead box protein M1. Mol Pharmacol 87:150-61 (2015). PubMed: 25391374
  • Vassilev B  et al. Elevated levels of StAR-related lipid transfer protein 3 alter cholesterol balance and adhesiveness of breast cancer cells: potential mechanisms contributing to progression of HER2-positive breast cancers. Am J Pathol 185:987-1000 (2015). PubMed: 25681734
  • Lai Q  et al. Positive correlation between the expression of hEag1 and HIF-1a in breast cancers: an observational study. BMJ Open 4:e005049 (2014). IHC-P ; Human . PubMed: 24838727
  • Stacpoole SR  et al. Neural precursor cells cultured at physiologically relevant oxygen tensions have a survival advantage following transplantation. Stem Cells Transl Med 2:464-72 (2013). PubMed: 23677643
  • O'Connell K  et al. Determination of the Proteomic Response to Lapatinib Treatment using a comprehensive and reproducible ion-current-based proteomics strategy. J Proteom Genom Res 1:27-42 (2013). PubMed: 29046878
  • Ward TM  et al. Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5. Oncogene : (2012). WB ; Human . PubMed: 22751112
  • Hurtado A  et al. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature 456:663-6 (2008). WB ; Human . PubMed: 19005469
  • Zhau HE  et al. Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer. Mol Carcinog 3:254-7 (1990). PubMed: 1978777
  • Meissner K  et al. Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease. Am J Pathol 137:1305-9 (1990). PubMed: 1701961
  • van de Vijver MJ  et al. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 319:1239-45 (1988). PubMed: 2903446

For licensing inquiries, please contact

Sign up